Matches in Nanopublications for { ?s ?p "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP118882.RAYRH_gkqoRFDLvMT75TUumdRjBUPLA94YTo4hoFgfviM130_assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118882.RAYRH_gkqoRFDLvMT75TUumdRjBUPLA94YTo4hoFgfviM130_provenance.
- assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182078.RAN-52I00dLl2dISXKtxijNh9fNxbziUB0WUD9NCtcuVA130_provenance.
- NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_provenance.
- NP206406.RA_UbESP7mmBRJEJ743Te5XKyqSyJ8Dqk3OAmz4hTcS4U130_assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206406.RA_UbESP7mmBRJEJ743Te5XKyqSyJ8Dqk3OAmz4hTcS4U130_provenance.